Middle-East And Africa Preclinical In-vivo Imaging Market By Modality (optical Imaging, Nuclear Imaging, Micro-MRI, Micro-CT, Micro-ultrasound, Photoacoustic, And Magnetic Particle Imaging Systems), By Reagent (optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, And CT Contrast Agents), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Middle-East And Africa Preclinical In-vivo Imaging Market By Modality (optical Imaging, Nuclear Imaging, Micro-MRI, Micro-CT, Micro-ultrasound, Photoacoustic, And Magnetic Particle Imaging Systems), By Reagent (optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, And CT Contrast Agents), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

ID: 587 | Pages: 130 | October 2018 | Region: Middle East and Africa


Overview of the Market:
Middle-East and Africa Preclinical in-vivo imaging market
has been estimated at USD 78.57 Million in 2018 and is projected to reach USD 105.3 Million by 2023, at a CAGR of 5.61% during the forecast period from 2018-2023. Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations.

Growing acceptance of preclinical imaging in drug discovery and development processes is slowly introducing the Middle-East and Africa market into the world scenario, by driving the market growth. However, high implementation cost of preclinical imaging devices is hampering the market growth in African countries.

Middle-East and Africa market for Preclinical In-vivo Imaging is segmented based on Modality and Reagents. Based on modality, the Middle-East and Africa preclinical imaging market is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems. The preclinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems market comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and tri-modality (PET/SPECT/CT) imaging systems. Bases on the reagents, the Middle-East and Africa preclinical imaging market is divided into five segments, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further sub-segmented as bioluminescent and fluorescent imaging reagents. Likewise, the nuclear imaging reagents market is divided as preclinical PET tracers and SPECT probes.

Geographical Analysis: 
Geographically, Middle-East and Africa market for Preclinical In-vivo Imaging is segmented Middle-East and Africa regions. Emerging markets offering lucrative growth is creating new growth opportunities for the preclinical imaging systems and reagents manufacturers in the countries of Middle-East and African regions.

key players in the market:
Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are the key players operating in the Middle-East and Africa preclinical imaging systems market.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Modality                

                                5.1.1 Optical imaging      

                                                5.1.1.1 Bioluminescence/fluorescence imaging systems

                                                5.1.1.2 Standalone fluorescence imaging systems

                                                5.1.1.3 Optical + X-ray/optical + CT imaging systems

                                5.1.2 Nuclear imaging    

                                                5.1.2.1 Micro-PET systems (standalone PET, PET/CT, and PET/MRI)

                                                5.1.2.2 Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)

                                                5.1.2.3 Tri-modality (PET/SPECT/CT) imaging systems

                                5.1.3 Micro-MRI               

                                5.1.4 Micro-CT  

                                5.1.5 Micro-ultrasound 

                                5.1.6 Photoacoustic        

                                5.1.7 Magnetic particle imaging systems               

                5.2 By Reagent                 

                                5.2.1 Optical imaging reagents   

                                                5.2.1.1 Bioluminescent reagents

                                                5.2.1.2 Fluorescent imaging reagents

                                5.2.2 Nuclear imaging reagents 

                                                5.2.2.1 Preclinical PET tracers

                                                5.2.2.2 Preclinical SPECT probes

                                5.2.3 MRI contrast agents            

                                5.2.4 Ultrasound contrast agents             

                                5.2.5 CT contrast agents               

6. Geographical Analysis                                              

                6.1 Introduction                               

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Aspect Imaging                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Biospace Lab S.A.                     

                8.3 Bruker Corporation                 

                8.4 LI-COR Biosciences                  

                8.5 Mediso Ltd.                

                8.6 MILabs B.V.                

                8.7 MR Solutions Ltd                      

                8.8 PerkinElmer               

                8.9 TriFoil Imaging                           

                8.10 FUJIFILM VisualSonics, Inc.                                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East & Africa Preclinical in-vivo imaging Market By Region, From 2018-2023 (USD Million)
  2. Middle East & Africa Preclinical in-vivo imaging Market By Modality, From 2018-2023 (USD Million)
  3. Middle East & Africa Preclinical Optical imaging Market By Region, From 2018-2023 (USD Million)
  4. Middle East & Africa Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2018-2023 (USD Million)
  5. Middle East & Africa Preclinical Standalone fluorescence imaging systems Market By Region, From 2018-2023 (USD Million)
  6. Middle East & Africa Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2018-2023 (USD Million)
  7. Middle East & Africa Preclinical Nuclear imaging Market By Region, From 2018-2023 (USD Million)
  8. Middle East & Africa Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2018-2023 (USD Million)
  9. Middle East & Africa Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2018-2023 (USD Million)
  10. Middle East & Africa Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2018-2023 (USD Million)
  11. Middle East & Africa Preclinical Micro-MRI Market By Region, From 2018-2023 (USD Million)
  12. Middle East & Africa Preclinical Micro-CT Market By Region, From 2018-2023 (USD Million)
  13. Middle East & Africa Preclinical Micro-ultrasound Market By Region, From 2018-2023 (USD Million)
  14. Middle East & Africa Preclinical Photoacoustic Market By Region, From 2018-2023 (USD Million)
  15. Middle East & Africa Preclinical Magnetic particle imaging systems Market By Region, From 2018-2023 (USD Million)
  16. Middle East & Africa Preclinical in-vivo imaging Market By Reagent, From 2018-2023 (USD Million)
  17. Middle East & Africa Preclinical Optical imaging reagents Market By Region, From 2018-2023 (USD Million)
  18. Middle East & Africa Preclinical Bioluminescent reagents Market By Region, From 2018-2023 (USD Million)
  19. Middle East & Africa Preclinical Fluorescent imaging reagents Market By Region, From 2018-2023 (USD Million)
  20. Middle East & Africa Preclinical Nuclear imaging reagents Market By Region, From 2018-2023 (USD Million)
  21. Middle East & Africa Preclinical PET tracers Market By Region, From 2018-2023 (USD Million)
  22. Middle East & Africa Preclinical SPECT probes Market By Region, From 2018-2023 (USD Million)
  23. Middle East & Africa Preclinical MRI contrast agents Market By Region, From 2018-2023 (USD Million)
  24. Middle East & Africa Preclinical Ultrasound contrast agents Market By Region, From 2018-2023 (USD Million)
  25. Middle East & Africa Preclinical CT contrast agents Market By Region, From 2018-2023 (USD Million)
  26. Middle East Preclinical in-vivo imaging Market By Modality, From 2018-2023 (USD Million)
  27. Middle East Preclinical Optical Imaging Market By Optical imaging, From 2018-2023 (USD Million)
  28. Middle East Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2018-2023 (USD Million)
  29. Middle East Preclinical in-vivo imaging Market By Reagent, From 2018-2023 (USD Million)
  30. Middle East Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2018-2023 (USD Million)
  31. Middle East Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2018-2023 (USD Million)
  32. Africa Preclinical in-vivo imaging Market By Modality, From 2018-2023 (USD Million)
  33. Africa Preclinical Optical Imaging Market By Optical imaging, From 2018-2023 (USD Million)
  34. Africa Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2018-2023 (USD Million)
  35. Africa Preclinical in-vivo imaging Market By Reagent, From 2018-2023 (USD Million)
  36. Africa Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2018-2023 (USD Million)
  37. Africa Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2018-2023 (USD Million)
Middle East And Africa Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Ov...
Latin America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Asia-pacific Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive B...
Europe Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder...
North America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder) And B...
Middle East And Africa Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Lab...
Latin America Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories...
Asia-Pacific Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories,...
Europe Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories, Refer...
North-America Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (Culture-based, PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospit...
Blood Culture Tests Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-202...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2019 Market Data Forecast
All Rights Reserved.